Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFEST Trial in frail older patients after ischemic stroke or transient ischemic attack
NL-OMON60828Phase 4Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in ischemic stroke and transient ischaemic attack (TIA), sponsored by Amsterdam University Medical Center. Started Apr 2025; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on NL-OMON60828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60828.